OTCMKTS:ULUR - Uluru Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Uluru Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.0001 -0.11 (-99.91 %) (As of 03/31/2020 10:03 AM ET) Add Compare Today's Range$0.00Now: $0.00▼$0.0050-Day Range$0.02MA: $0.04▼$0.1152-Week Range$0.01Now: $0.00▼$0.12Volume2 shsAverage Volume79,473 shsMarket Capitalization$23,260.00P/E RatioN/ADividend YieldN/ABeta1.81 ProfileAdvanced ChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include Aphthasol paste for the treatment of canker sores; OraDisc A for canker sores; and OraDisc B, which is used for the treatment and management of oral pain. ULURU Inc. and is headquartered in Addison, Texas.Read More Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ULUR Previous Symbol CUSIPN/A CIK1168220 Webhttp://www.uluruinc.com/ Phone214-905-5145Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$720,000.00 Price / Sales0.03 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees2 Outstanding Shares232,600,000Market Cap$23,260.00 Next Earnings DateN/A OptionableNot Optionable Receive ULUR News and Ratings via Email Sign-up to receive the latest news and ratings for ULUR and its competitors with MarketBeat's FREE daily newsletter. OTC:ULUR Rates by TradingView Uluru (OTCMKTS:ULUR) Frequently Asked Questions How has Uluru's stock been impacted by COVID-19 (Coronavirus)? Uluru's stock was trading at $0.0255 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ULUR shares have decreased by 99.6% and is now trading at $0.0001. View which stocks have been mosted impacted by Coronavirus. Has Uluru been receiving favorable news coverage? News stories about ULUR stock have been trending very positive on Tuesday, InfoTrie reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Uluru earned a news sentiment score of 3.2 on InfoTrie's scale. They also assigned news stories about the specialty pharmaceutical company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutUluru. Who are some of Uluru's key competitors? Some companies that are related to Uluru include Respirerx Pharmaceuticals (RSPI), Advanz Pharma (CXRXF), Aeolus Pharmaceuticals (AOLS), Affymax (AFFY), American Oriental Bioengineering (AOBI), Aoxing Pharmaceutical (AOXG), Bohai Pharmaceuticals Group (BOPH), Epirus Biopharmaceuticals (EPRSQ), ERBA Diagnostics (ERBA), FutureWorld (FWDG), GlobeImmune (GBIM), Immune Therapeutics (IMUN), Intec Pharma (NTEC), Mereo BioPharma Group (MREO) and Myrexis (MYRX). What other stocks do shareholders of Uluru own? Based on aggregate information from My MarketBeat watchlists, some companies that other Uluru investors own include Hexo (HEXO), Synergy Pharmaceuticals (SGYP), Magnegas Applied Tchnlgy Sltns (MNGA), Microbot Medical (MBOT), Jaguar Health (JAGX), HEXO (HEXO), Consolidated Water (CWCO), China Recycling Energy (CREG), ARM (ARMH) and Akari Therapeutics (AKTX). Who are Uluru's key executives? Uluru's management team includes the following people: Ms. Vaidehi A. Shah, Chairman & CEO (Age 42)Mr. P. K Ramachandran, Chief Financial Officer (Age 65) What is Uluru's stock symbol? Uluru trades on the OTCMKTS under the ticker symbol "ULUR." How do I buy shares of Uluru? Shares of ULUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Uluru's stock price today? One share of ULUR stock can currently be purchased for approximately $0.00. How big of a company is Uluru? Uluru has a market capitalization of $23,260.00 and generates $720,000.00 in revenue each year. Uluru employs 2 workers across the globe. View additional information about Uluru. What is Uluru's official website? The official website for Uluru is http://www.uluruinc.com/. How can I contact Uluru? Uluru's mailing address is 4410 BELTWAY DRIVE, ADDISON TX, 75001. The specialty pharmaceutical company can be reached via phone at 214-905-5145. MarketBeat Community Rating for Uluru (OTCMKTS ULUR)Community Ranking: 1.7 out of 5 ()Outperform Votes: 40 (Vote Outperform)Underperform Votes: 80 (Vote Underperform)Total Votes: 120MarketBeat's community ratings are surveys of what our community members think about Uluru and other stocks. Vote "Outperform" if you believe ULUR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ULUR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/31/2020 by MarketBeat.com StaffFeatured Article: What is a Derivative?
